Dermapharm Holding SE buy Maxi_Scalibusa
Summary
This prediction ended on 05.11.21 with a price of €89.65. The BUY prediction by Maxi_Scalibusa for Dermapharm Holding SE saw massive gains of 184.60%. A total of €1.57 was paid as dividends for this prediction. Maxi_Scalibusa has 50% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Dermapharm Holding SE | 5.606% | 5.606% | -14.500% | -58.879% |
iShares Core DAX® | 2.291% | 2.984% | 20.344% | 20.143% |
iShares Nasdaq 100 | 1.336% | -0.196% | 25.550% | 37.734% |
iShares Nikkei 225® | 1.132% | 2.488% | 13.163% | 1.261% |
iShares S&P 500 | 1.272% | 1.334% | 24.544% | 40.521% |
Comments by Maxi_Scalibusa for this prediction
In the thread Dermapharm Holding SE diskutieren
Dermapharm
In the thread Trading Dermapharm Holding SE